Marketwatch Buy Aurobindo Pharma, target price Rs 485: ICICI Securities Admin April 7, 2020 Taking Sandoz out of estimates, the brokerage now expects consolidated revenue growth in mid-single digit for Aurobindo over the next two years. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
